Photo of Vera Jean Suman

View Scopus Profile

Vera Jean Suman, PhD

  • 34284 Citations
  • 68 Scopus h-Index
1992 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vera Jean Suman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Survival Medicine & Life Sciences
letrozole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2005 2021

P-1: The Role of CHFR in Tumorigenesis and Paclitaxwl-Sensitivity in Breast Cance

Gendler, S. J., Vachon, C. M., Suman, V. J., Ingle, J. N., Lingle, W. L., Couch, F. J., Goetz, M. P., Haluska, P. R. J., Chen, J., Hawse, J. R., Wang, L. M., Visscher, D. W., Galanis, E., Ingle, J. N. & Ingle, J. N.

National Institutes of Health

7/1/05 → 8/31/21

Project: Research project

Breast Neoplasms
Research Personnel
Research
Biostatistics
Translational Medical Research

Research Output 1992 2019

  • 34284 Citations
  • 68 Scopus h-Index
  • 236 Article
  • 3 Review article
  • 2 Comment/debate
  • 1 Editorial
1 Citation (Scopus)

Commentary on “Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma” by Giovanni Barosi and Robert Peter Gale

Holstein, S. A., Suman, V. J. & McCarthy, P. L., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journal › Article

Autografts
Standard of Care
Multiple Myeloma
lenalidomide
1 Citation (Scopus)

Comparison of 99mTc-sestamibi molecular breast imaging and breast MRI in patients with invasive breast cancer receiving neoadjuvant chemotherapy

Hunt, K. N., Conners, A. L., Goetz, M. P., O’Connor, M. K., Suman, V. J., Kalari, K. R., Weinshilboum, R. M., Wang, L. M., Carter, J., McLaughlin, S., Moreno Aspitia, A., Gray, R., Northfelt, D. W. & Boughey, J. C., Jan 1 2019, In : American Journal of Roentgenology. 213, 4, p. 932-943 12 p.

Research output: Contribution to journal › Article

Technetium Tc 99m Sestamibi
Molecular Imaging
Breast
Breast Neoplasms
Drug Therapy
2 Citations (Scopus)

Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials?

Holstein, S. A., Suman, V. J. & McCarthy, P. L., Jan 1 2019, (Accepted/In press) In : Current Hematologic Malignancy Reports.

Research output: Contribution to journal › Article

Multiple Myeloma
Randomized Controlled Trials
Disease-Free Survival
Clinical Trials
Salvage Therapy
2 Citations (Scopus)

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

Goetz, M. P., Suman, V. J., Nakamura, Y., Kiyotani, K., Jordan, V. C. & Ingle, J. N., Aug 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 22, p. 1982-1983 2 p.

Research output: Contribution to journal › Article

Tamoxifen
Breast Neoplasms
Recurrence

The emerging role of CDK4/6i in HER2-positive breast cancer

O’Sullivan, C. C., Suman, V. J. & Goetz, M. P., Jan 1 2019, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journal › Review article

Open Access
Breast Neoplasms
Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Play Therapy
G1 Phase Cell Cycle Checkpoints